The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
Targeting post-translational modifications of histones for cancer therapy
Corresponding Author(s) : Y-C Hsu
Cellular and Molecular Biology,
Vol. 61 No. 6: Advances in molecular oncology: Closer analysis of recent breakthroughs
Abstract
Post-translational modifications (PTMs) on histones including acetylation, methylation, phosphorylation, citrullination, ubiquitination, ADP ribosylation, and sumoylation, play important roles in different biological events including chromatin dynamics, DNA replication, and transcriptional regulation. Aberrant histones PTMs leads to abnormal gene expression and uncontrolled cell proliferation, followed by development of cancers. Therefore, targeting the enzymes required for specific histone PTMs holds a lot of potential for cancer treatment. In this review article, we retrospect the latest studies in the regulations of acetylation, methylation, and phosphorylation of histones. We also summarize inhibitors/drugs that target these modifications for cancer treatment.
Keywords
Histone
post-translational modification
acetylation
methylation
phosphorylation
cancer.
Hsu, Y.-C., Hsieh, Y.-H., Liao, C.-C., Chong, L.-W., Lee, C.-Y., Yu, Y.-L., & Chou, R.-H. (2015). Targeting post-translational modifications of histones for cancer therapy. Cellular and Molecular Biology, 61(6), 69–84. Retrieved from https://mail.cellmolbiol.org/index.php/CMB/article/view/725
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX